Promising MND drug slows disease progression
Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND)…
September 22, 2022 - 4 minutes
Neurodegenerative disease
NodThera reveals positive results for inflammasome inhibitors
Biotech company NodThera has announced positive phase 1 clinical readouts for its first and second…
September 21, 2022 - 2 minutes
Collaboration to explore gene therapy products for neurodegenerative disorders
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
September 14, 2022 - 3 minutes
IRLAB’s partner Ipsen starts mesdopetam clinical studies
IRLAB Therapeutics AB, a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most…
September 6, 2022 - 3 minutes
Researchers identify possible target for type of sporadic ALS
Researchers have published two papers describing how they identified a potential new pathway for treating…
August 31, 2022 - 3 minutes
Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS
Peer-review research published in Frontiers in Pharmacology supports the broad spectrum mechanism of action of…
August 31, 2022 - 2 minutes
Scientists unravel mystery behind neurodegenerative disease protein
Scientists have unraveled the mystery behind the mechanism behind a type of protein that leads…
August 30, 2022 - 4 minutes
Biogen’s New Drug Application for first treatment of rare form of neurological disease accepted by FDA
A drug to target a rare genetic form of a neurological disease that affects the…
July 28, 2022 - 4 minutes
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
June 30, 2022 - 3 minutes
Sponsored
by WuXi AppTec
Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
September 22, 2021 - 7 minutes
AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
September 2, 2021 - 5 minutes
Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene
Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month.…
July 20, 2021 - 4 minutes
